← All trials
NCT05291325
N/AInterventional
Trials without FDA-defined phases, including trials of devices or behavioral interventions.
View on ClinicalTrials.gov ↗Timeline
- Start date
- May 25, 2022
- Primary completion
- Dec 30, 2022
- Completion date
- Feb 28, 2023
- First posted
- Mar 22, 2022
- Last posted
- Jul 19, 2022
- Enrollment
- 1300
- Arms / groups
- 3 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Changhai HospitalLead sponsor
- Inner Mongolia Medical UniversityCollaborator
- Qinghai UniversityCollaborator
- Southwest Medical UniversityCollaborator
- Changhai HospitalOverall official - principal investigator
- Changhai HospitalReponsible party - principal investigator
- Daping HospitalCollaborator
- Huizhou People's Central HospitalCollaborator
- Shandong UniversityCollaborator
- Jiao Tong UniversityCollaborator
- Jiao Tong UniversityCollaborator
- Shanxi Medical UniversityCollaborator
- Air Force Military Medical University, ChinaCollaborator
- Qingdao UniversityCollaborator
- Nanchang UniversityCollaborator
- Soochow UniversityCollaborator
- Jinlin UniversityCollaborator
- Dalian Medical UniversityCollaborator
- Central South UniversityCollaborator
- Yueqing People's HospitalCollaborator
- The First People's Hospital of Yunan ProvinceCollaborator
- Wuhan UniversityCollaborator
- Zunyi Medical CollegeCollaborator
- Changhai HospitalSponsor investigator
- Changhai HospitalOfficial
- People's Liberation Army of ChinaCollaborator
- Fudan UniversityCollaborator
- Wenzhou Medical UniversityCollaborator
- Wenzhou Medical UniversityCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.